Doctor profile · Federal record
Dr. Natasha Tiffany, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Bend, OR
- NPI 1972697167
- Accepts Medicare
- MIPS 67.7 / 100 · 2023
- 28 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
2500 Ne Neff RD
Bend, OR 977016015
(541) 706-5800
fax (541) 706-5911 - Additional location
-
441 Nw Elks Dr Ste 100
Corvallis, OR 973303744
(541) 768-4950
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- December 17, 2024
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Oregon #MD22929
- Medicaid
- OR #287215
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972697167. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
122,079
Distinct HCPCS
10
Medicare allowed
$2,182,457
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 35,250 | 31 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 20,400 | 30 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 16,200 | 37 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 11,940 | 35 | $23 | |
J9267 |
Injection, paclitaxel, 1 mg | 7,620 | 15 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,020 | 12 | $48 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 3,746 | 114 | $0 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 3,030 | 11 | $7 | |
J9041 |
Injection, bortezomib, 0.1 mg | 2,088 | 13 | $5 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,870 | 54 | $1 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 1,333. This provider delivers 92× the peer median.Open Payments
Industry payments received
All-time total
$925
Transactions
27
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $99.95 | |
| Adaptive Biotechnologies Corporation | 1 | $97.09 | |
| Merck Sharp & Dohme LLC | 3 | $90.30 | |
| GENZYME CORPORATION | 3 | $82.86 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $75.95 | |
| Janssen Biotech, Inc. | 2 | $66.52 | |
| Aveo Pharmaceuticals, Inc. | 4 | $65.00 | |
| Novartis Pharmaceuticals Corporation | 2 | $44.84 | |
| PFIZER INC. | 1 | $35.13 | |
| Astellas Pharma US Inc | 1 | $35.00 | |
| Acrotech Biopharma Inc. | 2 | $34.23 | |
| AstraZeneca Pharmaceuticals LP | 1 | $27.69 | |
| ABBVIE INC. | 1 | $25.58 | |
| Mirati Therapeutics, Inc. | 1 | $25.58 | |
| Rigel Pharmaceuticals, Inc. | 1 | $21.42 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,878
Patients
523
Total drug cost
$171,939
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 462 | 109 | $11,090 |
| Tamoxifen Citrate | Generic | 159 | 46 | $5,405 |
| Potassium Chloride | Generic | 147 | 47 | $2,207 |
| Eliquis (Apixaban) | Brand | 142 | 28 | $123,431 |
| Gabapentin | Generic | 142 | 37 | $2,096 |
| Exemestane | Generic | 136 | 34 | $15,830 |
| Acyclovir | Generic | 104 | 20 | $1,448 |
| Hydroxyurea | Generic | 88 | 19 | $2,935 |
| Prochlorperazine Maleate | Generic | 83 | 46 | $1,019 |
| Venlafaxine Hcl Er (Venlafaxine Hcl) | Brand | 81 | 13 | $1,150 |
Frequently asked questions
What is Dr. Natasha Tiffany's medical specialty?
Dr. Natasha Tiffany practices Hematology & Oncology Physician in Bend, OR.
Where does Dr. Natasha Tiffany practice?
Dr. Natasha Tiffany practices at 2500 Ne Neff RD, Bend, OR 977016015. Office phone: 5417065800.
What is Dr. Natasha Tiffany's NPI?
Dr. Natasha Tiffany's National Provider Identifier (NPI) is 1972697167, issued by NPPES.
Does Dr. Natasha Tiffany accept Medicare assignment?
Yes. Dr. Natasha Tiffany accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Natasha Tiffany commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.